Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancers|January 30, 2020
A Comprehensive Review of Calcium Electroporation -A Novel Cancer Treatment ModalityStine K Frandsen, Mille Vissing, Julie Gehl
Acta Oncologica (Stockholm, Sweden)|August 29, 2022
Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic reviewFreya A Bastrup, Mille Vissing, Julie Gehl
Dermatology (Basel, Switzerland)|March 31, 2021
Calcium Electroporation for Keloids: A First-in-Man Phase I StudyHanne Falk, Mille Vissing, Gitte Wooler, et al.
Cancers|February 11, 2023
Qualitative Investigation of Experience and Quality of Life in Patients Treated with Calcium Electroporation for Cutaneous MetastasesKitt Vestergaard, Mille Vissing, Julie Gehl, et al.
Case Reports in Dermatology|December 5, 2022
Calcium Electroporation for Management of Cutaneous Metastases in HER2-Positive Breast Cancer: A Case ReportKatrine Borres Jensen, Camilla Kjaer Lonkvist, Julie Gehl, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2024
Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological studyMille Vissing, Sandra Sinius Pouplier, Lars Munch Larsen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 2, 2023
Calcium electroporation in cutaneous metastases - A non-randomised phase II multicentre clinical trialMille Vissing, Mascha Pervan, John Pløen, et al.
Acta Dermato-Venereologica|May 7, 2024
An Explorative Study on Calcium Electroporation for Low-risk Basal Cell CarcinomaStine R Wiegell, Kristoffer Hendel, Christine S K Fuchs, et al.
BMJ Open|June 17, 2021
Study protocol designed to investigate tumour response to calcium electroporation in cancers affecting the skin: a non-randomised phase II clinical trialMille Vissing, John Ploen, Mascha Pervan, et al.
Pageof 1